SUPEMTEK

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Poland, UK.

Active ingredients

The drug SUPEMTEK contains a combination of these active pharmaceutical ingredients (APIs):

1	Influenza A virus subtype H1N1 haemagglutinin, recombinant
	Read more about Influenza, inactivated, surface antigen
2	Influenza A virus subtype H3N2 haemagglutinin, recombinant
	Read more about Influenza, inactivated, surface antigen
3	Influenza B virus Victoria lineage haemagglutinin, recombinant
	Read more about Influenza, inactivated, surface antigen
4	Influenza B virus Yamagata lineage haemagglutinin, recombinant
	Read more about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1833791, 1833803, 1833814, 1834466, 1834477, 1834488
GB	Medicines & Healthcare Products Regulatory Agency	395663, 395861
IT	Agenzia del Farmaco	049227010, 049227022, 049227034, 049227046, 049227059, 049227061
LT	Valstybinė vaistų kontrolės tarnyba	1091345, 1091346, 1091347, 1091348, 1091349, 1091350
PL	Rejestru Produktów Leczniczych	100445839